vs
Ascendis Pharma A/S（ASND）与Doximity, Inc.（DOCS）财务数据对比。点击上方公司名可切换其他公司
Ascendis Pharma A/S的季度营收约是Doximity, Inc.的1.4倍（$267.3M vs $185.1M），Ascendis Pharma A/S同比增速更快（42.3% vs 9.8%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 25.2%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
ASND vs DOCS — 直观对比
营收规模更大
ASND
是对方的1.4倍
$185.1M
营收增速更快
ASND
高出32.6%
9.8%
两年增速更快
ASND
近两年复合增速
25.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $185.1M |
| 净利润 | — | $61.6M |
| 毛利率 | 90.5% | 89.9% |
| 营业利润率 | — | 38.9% |
| 净利率 | — | 33.3% |
| 营收同比 | 42.3% | 9.8% |
| 净利润同比 | — | -18.1% |
| 每股收益（稀释后） | — | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDDOCS
| Q4 25 | $267.3M | $185.1M | ||
| Q3 25 | $230.7M | $168.5M | ||
| Q2 25 | $170.7M | $145.9M | ||
| Q1 25 | $109.0M | $138.3M | ||
| Q4 24 | $187.8M | $168.6M | ||
| Q3 24 | $62.5M | $136.8M | ||
| Q2 24 | $38.9M | $126.7M | ||
| Q1 24 | $103.6M | $118.1M |
净利润ASNDDOCS
| Q4 25 | — | $61.6M | ||
| Q3 25 | $-65.9M | $62.1M | ||
| Q2 25 | $-42.0M | $53.3M | ||
| Q1 25 | $-102.2M | $62.5M | ||
| Q4 24 | — | $75.2M | ||
| Q3 24 | $-107.1M | $44.2M | ||
| Q2 24 | $-118.1M | $41.4M | ||
| Q1 24 | $-141.5M | $40.6M |
毛利率ASNDDOCS
| Q4 25 | 90.5% | 89.9% | ||
| Q3 25 | 89.5% | 90.3% | ||
| Q2 25 | 80.1% | 89.2% | ||
| Q1 25 | 82.6% | 89.5% | ||
| Q4 24 | 91.9% | 91.6% | ||
| Q3 24 | 80.6% | 90.0% | ||
| Q2 24 | 68.2% | 89.3% | ||
| Q1 24 | 92.1% | 89.4% |
营业利润率ASNDDOCS
| Q4 25 | — | 38.9% | ||
| Q3 25 | 5.1% | 37.8% | ||
| Q2 25 | -33.5% | 37.4% | ||
| Q1 25 | -103.2% | 35.2% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | -167.3% | 38.8% | ||
| Q2 24 | -370.2% | 36.4% | ||
| Q1 24 | -51.2% | 35.5% |
净利率ASNDDOCS
| Q4 25 | — | 33.3% | ||
| Q3 25 | -28.5% | 36.8% | ||
| Q2 25 | -24.6% | 36.5% | ||
| Q1 25 | -93.7% | 45.2% | ||
| Q4 24 | — | 44.6% | ||
| Q3 24 | -171.5% | 32.3% | ||
| Q2 24 | -303.9% | 32.7% | ||
| Q1 24 | -136.6% | 34.4% |
每股收益（稀释后）ASNDDOCS
| Q4 25 | — | $0.31 | ||
| Q3 25 | — | $0.31 | ||
| Q2 25 | — | $0.27 | ||
| Q1 25 | — | $0.31 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.22 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | — | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $64.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $979.3M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDDOCS
| Q4 25 | $665.3M | $64.8M | ||
| Q3 25 | $582.2M | $169.2M | ||
| Q2 25 | $533.6M | $137.3M | ||
| Q1 25 | $559.4M | $209.6M | ||
| Q4 24 | $604.3M | $165.3M | ||
| Q3 24 | $675.6M | $184.2M | ||
| Q2 24 | $279.4M | $111.4M | ||
| Q1 24 | $345.9M | $96.8M |
股东权益ASNDDOCS
| Q4 25 | $-175.8M | $979.3M | ||
| Q3 25 | $-188.0M | $1.1B | ||
| Q2 25 | $-202.6M | $1.0B | ||
| Q1 25 | $-205.0M | $1.1B | ||
| Q4 24 | $-114.2M | $1.0B | ||
| Q3 24 | $-105.1M | $961.2M | ||
| Q2 24 | $-346.8M | $913.6M | ||
| Q1 24 | $-257.2M | $901.4M |
总资产ASNDDOCS
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $819.0M | $1.1B | ||
| Q1 24 | $866.7M | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $60.9M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDDOCS
| Q4 25 | $58.2M | $60.9M | ||
| Q3 25 | — | $93.9M | ||
| Q2 25 | — | $62.1M | ||
| Q1 25 | $-15.5M | $98.5M | ||
| Q4 24 | $-330.7M | $65.2M | ||
| Q3 24 | — | $68.3M | ||
| Q2 24 | — | $41.2M | ||
| Q1 24 | $-109.7M | $63.9M |
资本支出强度ASNDDOCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ASNDDOCS
| Q4 25 | — | 0.99× | ||
| Q3 25 | — | 1.51× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | — | 1.58× | ||
| Q4 24 | — | 0.87× | ||
| Q3 24 | — | 1.55× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
